ESC Premium Access

Type of oral anticoagulants and outcomes after transcatheter aortic valve implantation

Congress Presentation

About the speaker

Doctor David Jochheim

MVZ Jochheim Medizin, Hattingen (Germany)
3 presentations
0 follower

4 more presentations in this session

TAVI thrombosis - Current knowledge

Speaker: Professor A. Finkelstein (Tel-Aviv, IL)


Continued vs. interrupted oral anticoagulation in patients with atrial fibrillation undergoing transfemoral transcatheter aortiv valve implantation

Speaker: Doctor N. Mangner (Dresden, DE)


Comparison of safety and benefits between single vs. dual antiplatelet therapy in patients undergoing transcatheter bioprosthetic aortic valve replacement: a meta-analysis

Speaker: Doctor S. Javed (The Bronx, US)


Anti-thrombotic therapy after TAVI - State of the art

Speaker: Professor R. Kornowski (Petah Tikva, IL)


Access the full session

Maintenance of anti-thrombotic therapy after TAVI

Speakers: Doctor D. Jochheim, Professor A. Finkelstein, Doctor N. Mangner, Doctor S. Javed, Professor R. Kornowski

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb